Baxter Healthcare Corporation recalls Regadenoson Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Labeling: Missing Label
- Products
-
- Regadenoson Injection
- Where it was sold
-
Nationwide within the USA
Nationwide
- Units affected
- 60,594 units
- About this recall
- Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01